Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | SORD | Q00796 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27571765 | 0.82 | HCAR2 (0.65) | HCAR2KDM4EMAPT | |
| SCHEMBL24937770 | 0.81 | HCAR2 (0.53) | HCAR2KDM4EMAPTSORD | |
| SCHEMBL15033503 | 0.78 | HCAR2 (0.66) | HCAR2KDM4EMAPT | |
| SCHEMBL22955581 | 0.76 | KDM4E (0.61) | HCAR2KDM4EMAPTSORD | |
| SCHEMBL9203345 | 0.76 | HTR1A (0.74) | HCAR2 | |
| SCHEMBL10469604 | 0.75 | HTR1A (0.58) | HCAR2 | |
| SCHEMBL4558892 | 0.74 | KDM4E (0.71) | KDM4EMAPTSORD | |
| SCHEMBL11637734 | 0.73 | KDM4E (0.65) | HCAR2KDM4EMAPTSORD | |
| SCHEMBL13591224 | 0.73 | KDM4E (0.65) | KDM4EMAPTSORD | |
| SCHEMBL20428029 | 0.73 | KDM4E (0.65) | KDM4EMAPTSORD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230024778-A1 | STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND | THE UNIVERSITY OF TOKYO (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024778-A1 | STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND | UTS2R, TAS1R1, ULK3 | HCAR2 565/4885KDM4E 4377/4885MAPT 958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.